Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
5.30
+0.08 (1.53%)
Apr 24, 2025, 9:36 AM EDT - Market open
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $84.48 million as of April 24, 2025. Its market cap has decreased by -6.61% in one year.
Market Cap
84.48M
Enterprise Value
91.62M
1-Year Change
-6.61%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $84.48M, a decrease of -72.94%. That is a compound annual growth rate of -49.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 80.49M | 46.45% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.68B |
| UnitedHealth Group | 389.92B |
| Johnson & Johnson | 373.39B |
| AbbVie | 312.01B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.63B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |